Skip to main content
Account

Table 1 Data for plotting the isobole

From: Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells

DXR

LV

Additive effect, (Pd)D + (Pd)L

Addition dose, (DoseD + DoseL) (μM)

Dose pair, (DoseD,DoseL) (μM)

Pd = 0.4865 − 0.2606 lgdose (R2 = 0.9529)

Pd = 1.092 − 0.05881 dose (R2 = 0.9808)

(1-Pd) C

DoseD (μM)

(1-Pd)L

DoseL (μM)

0%

0

50%

10.066

50%

10.066

(0,10.066)

10%

0.0259

40%

8.3659

50%

8.3918

(0.0259,8.3659)

20%

0.0627

30%

6.6655

50%

6.7282

(0.0627,6.6655)

30%

0.1516

20%

4.9651

50%

5.1167

(0.1516,4.9651)

40%

0.3668

10%

3.2648

50%

3.6316

(0.3668,3.2648)

50%

0.8876

0%

0

50%

0.8876

(0.8876,0)

  1. Where “Pd” is cell viability and (1-Pd) is the cell death

Navigation